A detailed history of Fundamentun, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Fundamentun, LLC holds 2,580 shares of ABT stock, worth $289,759. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,580
Previous 2,737 5.74%
Holding current value
$289,759
Previous $284,000 3.52%
% of portfolio
0.02%
Previous 0.03%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$100.07 - $118.13 $15,710 - $18,546
-157 Reduced 5.74%
2,580 $294,000
Q2 2024

Jul 24, 2024

BUY
$100.73 - $112.44 $275,698 - $307,748
2,737 New
2,737 $284,000
Q4 2022

Jan 19, 2023

SELL
$95.06 - $111.52 $18,726 - $21,969
-197 Reduced 8.17%
2,214 $0
Q3 2022

Oct 24, 2022

BUY
$96.76 - $112.03 $15,965 - $18,484
165 Added 7.35%
2,411 $233,000
Q2 2022

Sep 06, 2022

SELL
$102.07 - $123.37 $12,962 - $15,667
-127 Reduced 5.35%
2,246 $244,000
Q1 2022

Apr 26, 2022

SELL
$114.02 - $139.04 $26,680 - $32,535
-234 Reduced 8.98%
2,373 $281,000
Q4 2021

Jan 14, 2022

SELL
$115.53 - $141.46 $249,544 - $305,553
-2,160 Reduced 45.31%
2,607 $367,000
Q3 2021

Oct 19, 2021

BUY
$116.66 - $129.06 $556,118 - $615,229
4,767 New
4,767 $563,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fundamentun, LLC Portfolio

Follow Fundamentun, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fundamentun, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fundamentun, LLC with notifications on news.